Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DOXORUBICIN-RELATED CARDIOTOXICITY: REVIEW OF FUNDAMENTAL PATHWAYS OF CARDIOVASCULAR SYSTEM INJURY
Ashot Avagimyan, Nana Pogosova, L. V. Kakturskiy, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107683-107683
Closed Access | Times Cited: 12

Showing 12 citing articles:

Inhibition of NETs prevents doxorubicin-induced cardiotoxicity by attenuating IL-18-IFN-γ-Cx43 axis induced cardiac conduction abnormalities
Kun Li, Kunmao Jiang, Yu Wang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114016-114016
Closed Access | Times Cited: 1
Comprehensive review of non-invasive treatment related cardiovascular toxicity in breast cancer
C Li, Huijuan Dai, Xinning Guo, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 111759-111759
Closed Access
THE ROLE OF MATRIX METALLOPROTEINASE-9 AS A BIOLOGICAL MARKER IN HEART FAILURE
Albina B. Sultangalieva, Amina M. Alieva, Alik M. Rakhaev, et al.
Russian Medicine (2025)
Closed Access
Doxorubicin-induced cardiometabolic disturbances: what can we do?
Ashot Avagimyan, Nana Pogosova, Manfredi Rizzo, et al.
Frontiers in Clinical Diabetes and Healthcare (2025) Vol. 6
Open Access
Beneficial Effects of Butyrate on Kidney Disease
Tram N. Diep, Haoxin Liu, Liang‐Jun Yan
Nutrients (2025) Vol. 17, Iss. 5, pp. 772-772
Open Access
The role of HDAC2 inhibition in cardioprotection against doxorubicin-induced myocardial injury
Jinsha Liu, Wenwen Fu, Xue Wang, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2025) Vol. 10, Iss. 1, pp. 101-109
Open Access
Cardiomyopathies and a brief insight into DOX-induced cardiomyopathy
Sampat Singh Tanwar, Sumeet Dwivedi, Sheema Khan, et al.
The Egyptian Heart Journal (2025) Vol. 77, Iss. 1
Open Access
Metabolomic profiling and biomarker identification for early detection and therapeutic targeting of doxorubicin-induced cardiotoxicity
Jingjing Ding, Xianzhen Feng, Zhongqing Xu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Preconditioning of human iPSCs with doxorubicin causes genome-wide transcriptional reprogramming in iPSC-derived cardiomyocytes linked to mitochondrial dysfunction and impaired cardiac regeneration
Michelle Westerhoff, Nahal Ahmadinejad, Yulia Schaumkessel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Doxorubicin Incorporation into Gold Nanoparticles: An In Vivo Study of Its Effects on Cardiac Tissue in Rats
Patricia Lorena Cîmpan, Camelia Alexandra Coadă, Adrian Florea, et al.
Nanomaterials (2024) Vol. 14, Iss. 20, pp. 1647-1647
Open Access | Times Cited: 1
DOXORUBICIN AND CYCLOPHOSPHAMIDE MODE OF CHEMOTHERAPY–RELATED CARDIOMYOPATHY: REVIEW OF PRECLINICAL MODEL
Ashot Avagimyan, L. V. Kakturskiy, Nana Pogosova, et al.
Current Problems in Cardiology (2024), pp. 102882-102882
Closed Access | Times Cited: 1
Anthracycline-Induced Subclinical Right Ventricular Dysfunction in Breast Cancer Patients: A Systematic Review and Meta-Analysis
Andrea Faggiano, Elisa Gherbesi, Chiara Giordano, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3883-3883
Open Access
Page 1

Scroll to top